Variable | Categories | Risk of positive blood smear on day 2 | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|---|
RR* (95% CI) | p-value | RR†(95% CI) | p-value | |||
Anti-malarial treatment | DP | 5.7% | 1.0 (reference) | - | Not included in final model | |
AL | 5.6% | 1.03 (0.55-1.95) | 0.92 | |||
mg/kg dosing of anti-malarial | ≥ median (DP) | 5.8% | 1.0 (reference) | - | Not included in final model | |
< median (DP) | 5.6% | 1.00 (0.41-2.43) | 0.99 | |||
≥ median (AL) | 4.0% | 1.0 (reference) | - | |||
< median (AL) | 7.1% | 1.74 (0.70-4.38) | 0.23 | |||
Temperature °C | < 37.0 | 2.6% | 1.0 (reference) | - | 1.0 (reference) | - |
37.0-37.9 | 5.9% | 2.35 (0.98-5.59) | 0.05 | 2.32 (1.01-5.31) | 0.048 | |
≥ 38.0 | 7.8% | 3.09 (1.28-7.46) | 0.01 | |||
Parasite density per μL | < 4,000 | 1.4% | 1.0 (reference) | - | 1.0 (reference) | - |
4,000-20,000 | 1.3% | |||||
> 20,000 | 8.3% | 5.79 (2.35-14.3) | <0.001 | 5.12 (2.12-12.37) | <0.001 | |
Haemoglobin g/dL | ≥ 10 | 5.4% | 1.0 (reference) | - | Not included in final model | |
< 10 | 6.0% | 1.06 (0.46-2.45) | 0.89 | |||
HIV status | Negative | 5.0% | 1.0 (reference) | - | 1.0 (reference) | - |
Positive | 19.4% | 3.87 (1.85-8.12) | <0.001 | 3.69 (1.54-8.84) | 0.003 | |
Episode number | 1-2 | 6.9% | 1.0 (reference) | - | Not included in final model | |
3-4 | 5.1% | 0.74 (0.37-1.48) | 0.39 | |||
≥5 | 3.7% | 0.50 (0.20-1.29) | 0.15 |